US SB1268 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 1 2019 - 25% progression, died in committee
Action: 2019-05-01 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 1 2019 - 25% progression, died in committee
Action: 2019-05-01 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Specifies that payment under Medicare to a hospital for the acquisition costs of an allogeneic hematopoietic stem cell transplant (e.g., bone marrow transplant from a donor) must be made on a reasonable cost basis (similar to the current payment methodology for solid organ acquisitions). The Centers for Medicare & Medicaid Services must determine included items through regulations.
Title
PACT Act Patient Access to Cellular Transplant Act
Sponsors
Sen. Debbie Stabenow [D-MI] | Sen. Richard Burr [R-NC] | Sen. Sherrod Brown [D-OH] | Sen. Tim Scott [R-SC] |
Sen. Chris Van Hollen [D-MD] | Sen. Amy Klobuchar [D-MN] | Sen. Todd Young [R-IN] |
History
Date | Chamber | Action |
---|---|---|
2019-05-01 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
HB2498 (Same As) 2019-05-02 - Referred to the House Committee on Ways and Means.
HB1865 (Related) 2019-12-20 - Became Public Law No: 116-94. (TXT | PDF)
HB1865 (Related) 2019-12-20 - Became Public Law No: 116-94. (TXT | PDF)
Subjects
Blood and blood diseases
Cell biology and embryology
Health
Hospital care
Immunology and vaccination
Medicare
Organ and tissue donation and transplantation
Cell biology and embryology
Health
Hospital care
Immunology and vaccination
Medicare
Organ and tissue donation and transplantation
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/1268/all-info |
Text | https://www.congress.gov/116/bills/s1268/BILLS-116s1268is.pdf |